Question 1

What is the overall treatment approach for anxiety disorders?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

Question 2

How do I choose between medication and therapy for anxiety?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

Question 3

What is stepped care for anxiety?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

Question 4

How long should anxiety treatment last?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

Question 5

When should I combine medication and therapy?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

Question 6

What are the barriers to anxiety treatment?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

Question 7

Are there new treatments for anxiety on the horizon?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

Question 8

How do I taper anxiety medication?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

Question 9

What digital tools work for anxiety?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

Question 10

Is anxiety overdiagnosed?

Accepted Answer

The overall treatment approach for anxiety disorders follows a stepped-care framework: identify the disorder accurately, start with first-line treatment (SSRI/SNRI, CBT with exposure, or combination depending on severity and diagnosis), monitor with validated instruments, maintain treatment for at least 12 months after remission, and step up when initial approaches are insufficient. Only ~10% of people with anxiety disorders receive minimally adequate treatment worldwide. The treatment gap concentrates along lines of race, income, and geography. Emerging pharmacotherapies (psilocybin, ketamine) are not ready to replace established treatments. Digital therapeutics (guided iCBT) represent the most scalable near-term solution to the access crisis.

PsychHQ

What's the Overall Treatment Approach for Anxiety?